Evaluating decision-making in patients with epilepsy by Strazar, Abbey
Evaluating Decision-Making in Patients with 
Epilepsy 
 
Submitted as part of Abbey Strazar’s Undergraduate Thesis 
 
 
 
 
 
 
May 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
James W. McAuley, PhD, Advisor 
Yun Jeong Lee, OSU P4 Student, Co-Investigator 
  
 
2
BACKGROUND 
 The OSU Medical Center’s Comprehensive Epilepsy Program is in a never-ending cycle of trying to 
improve the care of patients with epilepsy through asking patient preferences about their care [1], describing 
their perceived risk of epilepsy & its treatment [2] and ranking their concerns [3]. Many patients are seen in the 
outpatient epilepsy clinic on a routine basis. The goal for patients with epilepsy is “No seizures & No side 
effects”. As antiepileptic drugs are the mainstay of treatment for nearly all epilepsy patients, much of what is 
done in clinic is to provide drug therapy recommendations with the goal to decrease seizure burden and/or 
lessen adverse drug effects. The ultimate decision-maker on whether they will follow the given advice is the 
patient and/or their family. Thus, as one member of the care team puts it, “We are in the advice business”.  
 Experience over many years has demonstrated that when patients are given advice about changes to their 
drug therapy regimen, some follow it completely, some selectively follow it and others ignore it. Many patients 
follow advice, but three recent patient interactions have highlighted those who do NOT follow 
recommendations. 
 Case 1 – A young woman with uncontrolled seizures who recently had drug access barriers 
removed. Despite this aid, she failed to take her medicines routinely and continued to have seizures. At 
her most recent routine follow-up visit, she was re-educated on the benefits of taking antiepileptic drugs. 
It is unclear why she does not follow recommended changes to her drug therapy regimen. 
 Case 2 –A young professional woman of childbearing age who did not want to take daily folic 
acid supplementation which could help reduce the risk of teratogenicity if she became pregnant on her 
antiepileptic drug. Despite education from the practitioners, she stated she was not interested in “taking 
another pill”. 
 Case 3 – A young man with recent seizure activity who stated he did not want to take any 
medicines on a daily basis for his seizures. Yet he took alternative medicines daily to try and combat the 
seizures. Through intensive patient education, he agreed to try a new antiepileptic drug to be taken on a 
daily basis. 
Needless to say, these patient interactions are puzzling. They highlight the need to learn more about how 
patients with epilepsy make drug-therapy decisions. As Lloyd and colleagues cite in their recent paper “to 
include patients’ preferences in clinical decision making, there is a need for accurate information regarding the 
nature of the preference [4].”  These authors provided some insight into patients with epilepsy’s decision 
making when they compared the value that patients put on seizure control versus the adverse events of 
antiepileptic drugs. They measured patient preferences through a discrete choice method asking patients to 
make choices in scenarios where drugs could give seizure control vs. adverse effects. Not unexpectedly, their 
data suggests that patients with epilepsy have strong preferences for improving seizure control and reducing 
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adverse effects. Beyond this recent paper, there is little in the literature about how patients with epilepsy make 
decisions regarding their drug therapy choices. Our assumption is that patients fall somewhere along this scale 
when it comes to their drug-therapy decisions. 
 
0=Never Follow            100=Always 
Advice             Follow Advice 
 
If we can learn more about how patients make drug therapy change decisions, perhaps we can “move” 
them further toward the right of the scale. The objective of this project is to determine why patients with 
epilepsy do or do not follow suggested advice to change their antiepileptic drug therapy. 
 
METHODS 
 This is an anonymous, cross-sectional study assessing the drug-therapy decision making process of 
patients with epilepsy.  If patients fit the following criteria they were asked at their Epilepsy clinic visit to be 
part of the study: 
 Inclusion Criteria 
• Adult (>17 yrs) with a diagnosis of epilepsy 
• Taking at least one antiepileptic drug 
• Able to complete questionnaires 
• Have at least one change to their current drug regimen suggested at their clinic visit 
• Have a valid mailing or email address 
 Exclusion Criteria 
• History of non-epileptic seizures 
• Prisoner 
• Pregnancy 
After verbal consent was obtained (attached), the patients were asked to provide their mailing or email 
address.  Patient tracking data were entered into a secure, online, interactive database that was set up by an 
Information Technology Specialist (A. Khurma) from the College of Pharmacy.  Four weeks after their clinic 
visit, patients were sent a survey (attached) in the mail or an email was sent that included a link to an online 
survey (www.Qualtrics.com).  The survey asks questions about whether or not they listened to their health care 
provider’s advice. 
If patients complete the survey online, the data is stored online in a password-protected file on 
www.Qualtrics.com.  If patients completed the survey via mail, the returned surveys are manually entered into 
  
 
4
the Qualtrics database.  There are no tracking codes associated with any of the surveys, thus the data are not 
associated with patient data.  We are doing this anonymously so patients are free to tell us their opinion 
without concern of connecting it back to them.  Patients do not receive any compensation for completing the 
surveys, but they are told that for every completed survey, $5 will be donated to the local Epilepsy Foundation 
of Central Ohio by the Principal Investigator (Dr. McAuley). 
 
 
RESULTS 
 Although patient enrollment is not complete (target=100 patients), the data as of May 4, 2011 is 
presented below.  As of May 4, 2011, we have recruited 55 patients.  Fifty-one surveys have been sent 
invitations either by mail or email thus far.  One patient’s mailed survey was returned “undeliverable” due to a 
non-current address.  To date we have received 28 responses for a response rate of 56%.  Table 1. describes 
the demographics of the respondents.  In addition to gathering pertinent demographic data, we asked patients 
to measure the impact of their seizures on their daily life (1 = “no impact” 10 = “impacts life tremendously”).  
The mean value was 5.96 ± 2.82. 
Table 1.  Patient Demographics 
N 28 
Gender 19 Females 
7 Males 
Age Mean age 41.3 years ( range from 27-56 years) 
Age of first seizure Mean age 19.0 years ( range from 9 months-49 years) 
Type of seizures 9 “Grandmal” 
3 Tonic Clonic 
4 Partial Complex 
5 Unsure of the name 
5 Multiple forms 
Number of seizure medications 2.00 (±0.87) 
Have conditions beyond epilepsy 12 yes 
13 no 
Total number of medications Mean number 4.36 (range from 1-8) 
Impact of seizure on everyday life ( 1=none, 10= a 
lot) 
5.96 (±2.82)  
How long since last seizure? 9    within the last 30 days 
9    1-6 months ago 
2    6-12 months ago 
5    more than 12 months ago 
 
Figure 1 describes what drug 
regimen changes were suggested at their 
clinic visit.  Patients could choose more 
than one option. 
Figure 1.
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As can be seen from the Figure 2, a majority of respondents (89.3%) stated that they followed the 
practitioner’s advice when it came to making changes to their drug regimen.  The patients who followed the 
suggestion stated that their reasoning had been that 
they wanted fewer seizures and fewer side effects.  
They also followed the recommendation to change 
their drug therapy because they truly trust their 
practitioner.  Conversely, of the 3 people that 
answered no, their main reason to not listening was for 
fear of medication side effects and of pure annoyance to the change in their drug regimen.  
 Because we are looking to increase the number of patients who follow their physicians advice verses 
patients who do not, we asked the question, “What are some reasons why you would follow your Practitioners 
recommendations?” The top 3 reasons were as follows: 
1. They are Epilepsy Specialists 
2. They took time to listen to me 
3. Took the time to explain reasoning and have my best interest in mind 
When asked what would be some reasons why you would not listen to your physician’s advice the top 2 
reasons were: 
1. Cost 
2. Did not understand the changes being made or physician did not listen to what I had to say 
When asked if there was anything that the Outpatient Neurology Clinic could do to make its patients more 
receptive to the practitioners recommendations concerning their drug therapy, there seemed to be themes that 
emerged from the patient responses.  Five patients suggested that the physician should explain changes and 
give detailed information about the drug that is in question.  However, nine patients had similar statements that 
consisted of: “I am happy at the current time”, or “nothing; my practitioner has done everything I’ve wanted”.   
Additionally, participants were asked to tell us their current status of adherence when it comes to 
drug-therapy changes.  The number line ranged from 0 to 100 with 0 referring to “never follows advice” and 
100 referring to “always follows 
advice.” These results are graphically 
depicted in Figure 3 and are 
consistent information from similar 
questions. 
 
Figure 2. Responses to 
“Did you follow the 
advice to change your 
drug regimen?” 
Figure 3. 
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DISCUSSION 
 After the challenging tasks of developing a research question, getting Biomedical Institutional Review 
Board (IRB) approval, and recruiting patients, this study has provided initial data to help us understand the 
decision-making process of patients.  Within the past 8 months we have obtained enough data to begin 
assessing why certain patients follow their practitioners advice while others tend to stray away from their 
suggestions. Following IRB approval, I have had an active role in this study.  I have continually met with 
Dr.McAuley to discuss topics that included: the direction of our research, responses thus far, and conflicts or 
misunderstandings that arose during clinic.  For example, at a patient’s previous clinic visit there was a change 
to their drug regime.  However, once leaving the clinic they failed to follow their practitioner’s advice.  As a 
result, at their next appointment the practitioner decided to stick to his previous drug-therapy change and the 
patient finally agreed to cooperate.  It was then up to us to discuss whether or not a change had been made to 
their drug regime and determine if they fit our criteria. It has also been my role to help recruit patients in clinic, 
enter returned mailed surveys properly into the Qualtrics database, and track the distribution of surveys 4 weeks 
after participants clinic visit. 
 We have previously suggested that there are three different domains of cooperation that a patient can fall 
under.  One extreme is that the patient follows every suggestion that their practitioner utters, the other extreme 
is that they repeatedly tend to disagree and ignore their practitioner’s recommendation.  The middle of the two 
extremes is a patient who is inconsistent with listening to the practitioner’s advice; this is our population of 
interest.  The advice he/she will follow is based on their knowledge, or lack thereof, to the treatment in 
question.  The significance of our survey is to use the results to develop different techniques to help 
practitioners understand their patient’s needs and wants.  This in effect might help persuade the middle domain 
patients to choose to listen to their practitioner verses ignoring their counsel.  Though it is more of a challenge, 
we have not forgotten about the group that is less inclined to heed advice.  We hope to learn things that may be 
beneficial to them as well. 
 As England and Evans stated in their paper, Active Patient Orientation, which is the extent to which 
patients participate in the decision-making process, monitor their own progress, and become educated about 
their disease state [5], might maximize therapeutic response and patient cooperation.  By analyzing the 
responses to our questions we will be able to better understand patients’ decision-making process and develop a 
technique to help persuade the “middle domain patients” to lean more towards the “yes domain”.  As it was 
stated in the RESULTS section, one of the main reasons that patients follow therapeutic recommendations is 
because the practitioner took time to listen and explain the reasoning to them.  Likewise, the main reason why 
patients would NOT follow the alterations was because they did NOT understand the changes being made or the 
physician was not taking into consideration the concerns of the patient.  The common trend is that patients 
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want to take part in the decision-making process and make sure that their opinions and concerns are being heard 
by their epilepsy specialist.  Further research should help evaluate this concern. Once our target sample size of 
100 has been obtained and every survey has been sent we can begin assessing the completed dataset and using 
our results to better understand our patients.    
 Our study is not without limitations.  They include, but are not limited to, less than 100% response rate, 
incomplete data from those that responded, a cross-sectional approach, the use of a non-validated survey, and 
all the data are from patients seen at a single Comprehensive Epilepsy Program. 
 
POTENTIAL SIGNIFICANCE 
 By asking patients to provide anonymous feedback to us after their visit, we hope to learn more about 
how and why they make decisions regarding their drug therapy.  With feedback from patients, we plan to then 
use that knowledge to improve patient care in our clinic and hopefully set an example for other health 
professionals.  
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CONSENT SCRIPT 
 
The following information is explained to each eligible patient before they are asked to provide their mail or 
e-mail address. 
 
 
The purpose of this study is to learn more about the decision-making of patients with epilepsy.  You will be 
sent a survey either by mail or e-mail asking you about how you approached the recent suggested changes to 
your medications. You will also be asked to answer questions to describe yourself.  The survey will be sent out 
4 weeks after your clinic visit today.  The survey should take less than 15 minutes to complete and you will 
complete the survey only once.  
 
We do not expect any risk to you for participating.  As your responses will be anonymous, you will not directly 
benefit.  But, patients with epilepsy in general may benefit because the practitioners in this clinic may learn 
how patients make decisions regarding medication changes.  As a thank you for you sending back your survey 
or completing it online, we will donate $5 to the Epilepsy Foundation of Central Ohio for each completed 
survey.  If you do not want to be part of the study, you can always tell us your concerns. 
 
Your responses will not be shared with anyone outside the study.  If you have any questions about the study, 
please don’t hesitate to ask me or your practitioner.  Your participation is voluntary; you may choose not to 
participate without penalty or loss of benefits to which you are otherwise entitled.  If you have any questions, 
you can call Dr. Jim McAuley at 614-292-9713.  
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Hello OSU Epilepsy Clinic Patient, 
 
We are continually striving to try and do a better job for our patients.  At your recent clinic visit when we advised you to make a 
change to your drug regimen, you agreed to fill out a survey.  Please answer the questions below and send the completed survey back 
to us in the postage-paid envelope included.  
  
We do not expect any risk to you for participating.  As your responses will be anonymous, you will not directly benefit.  But, 
patients with epilepsy in general may benefit because the practitioners in this clinic may learn how patients make decisions regarding 
medication changes.  As a thank you for you sending back your survey or completing it online, we will donate $5 to the Epilepsy 
Foundation of Central Ohio for each completed survey.  If you do not want to be part of the study, you can always tell us how you 
make decisions about medication changes. 
 
Your responses will not be shared with anyone outside the study.  Your participation is voluntary; you may choose not to participate 
without penalty or loss of benefits to which you are otherwise entitled.  If you have any questions, please don’t hesitate to contact Dr. 
Jim McAuley (614-292-9713 or mcauley.5@osu.edu or mailing address:  OSU College of Pharmacy, 500 West 12th Ave, Columbus, 
OH  43210).  
  
SURVEY 
 
1) Which of the following changes were recommended to you at your clinic visit 4 weeks ago?  Choose all that apply. 
o Increase dose of current medication(s)  
o Decrease dose of current medication(s)  
o Addition of a new drug  
o Addition of folic acid  
o Addition of calcium  
o Other   
 
 
 
 
2) Did you follow that advice? 
o Yes (please go on to question #3) 
o No (please skip to question #4) 
      
3) What was the PRIMARY reason you DID follow that advice? (Please check only one)  
o I want to have less seizures  
o I want to have less medication side effects  
o I trust my practitioner  
o Other   
 
 
 
4) What was the PRIMARY reason you DID NOT follow that advice? (Please check just one)  
o Cost  
o Fear of medication side effects  
o Concern over drug interactions  
o Fear of seizures getting worse  
o I forgot what the change was  
o I'm happy with my current seizure control  
o Other    
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5) What, if any, were OTHER reasons you did or did not follow the advice on making changes to your drug regimen?  
 
 
 
 
 
 
 
 
 
6) Did you tell your Practitioner about your decision?  
o Yes  
o No  
  
7) Why or why not did you decide to tell/ not tell your practitioner about your decision?  
 
 
 
 
 
 
 
 
 
8) What are some reasons why you WOULD follow your Practitioners recommendations (check all that apply)?  
o I received a handout to help me understand the changes  
o They took time to explain the changes  
o They took time to listen to me  
o They are an Epilepsy Specialist  
o They have my best interest in mind  
o Other   
 
 
 
 
 
9) What are some reasons why you WOULD NOT follow your Practitioner's recommendations (check all that apply)?  
 They didn't understand or listen to me  
o I didn't understand what the changes were  
o I didn't understand why the changes were being made  
o I felt forced/threatened  
o Cost  
o I don't trust them  
o I had a bad experience with a past Practitioner  
o I read something on the internet  
o Other   
 
 
 
 
 
10) What can this clinic do to make you more receptive to our recommendations about your drug therapy? 
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11) Please circle the value below telling us where you think you are when it comes to accepting drug-therapy changes.  
     
Never=0%            Always=100% 
0 10 20 30 40 50 60 70 80 90 100 
 
 
12)  In what year were you born? ____________________ 
  
13) I am:  
o Female   
o Male   
     
14) How old were you when you had your first seizure? _______________ years old. 
  
15) What type of seizures do you have?  
 
 
 
 
 
16) How many different seizure medicines do you take regularly?  
o 1  
o 2  
o 3  
o 4 or more   
 
17) Do you have conditions beyond epilepsy?  
o Yes   
o No   
     
18) What is the total number of all of your medications? _________________________________________  
 
 
 19) On a scale of 1 to 10 (1 being none and 10 being a lot), how much impact do your seizures have on your daily life? (Circle 
the value below) 
     
1 2 3 4 5 6 7 8 9 10 
 
 
20) When was your last seizure?  
o In the last 30 days  
o Between 1 and 6 months ago  
o Between 6 and 12 months ago  
o More than 12 months ago  
o I'm not sure   
 
 
THANK YOU! 
 
 
